
NEWSROOM
CARDIALEN IN THE NEWS
EP Lab Digest
"Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment"
Mass Device
"Cardialen gets FDA IDE nod for low-energy AFib treatment"
https://www.massdevice.com/cardialen-gets-fda-ide-nod-for-low-energy-afib-treatment/
Cardiac Rhythm News
"Cardialen gets FDA approval for study of its Multipulse Therapy for AF"
MD+DI
"When They Go High We Go Low: Using Low Energy to Treat AFib"
https://www.mddionline.com/cardiovascular/when-they-go-high-we-go-low-using-low-energy-treat-afib
BioWorld
"Cardialen wins FDA IDE approval for low-energy pulse therapy"
Twin Cities Business
"Medtech Firm Cardialen to Kick Off Fifth Clinical Trial"
https://tcbmag.com/medical-device-maker-cardialen-to-kick-off-fifth-clinical-trial/
CARDIALEN PRESS RELEASES
11.17.21 PRESS RELEASE
09.16.21 PRESS RELEASE
Cardialen Awarded $3 Million Federal Grant
04.13.21 PRESS RELEASE
01.19.21 PRESS RELEASE
Cardialen Awarded $2.8 Million Federal Grant
01.19.21 BUSINESWIRE PRESS RELEASE
Cardialen Awarded $2.8 Million Federal Grant
10.10.18 PRESS RELEASE
Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy
10.10.18
Minneapolis startup Cardialen raises $17 million in venture capital
Star Tribune
Media contact:
Michael Walsh
(612) 718-8952
MichaelWalshCommunications.com